These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3565907)

  • 21. In vitro neutralization of heparin in plasma prior to the activated partial thromboplastin time test: an assessment of four heparin antagonists and two anion exchange resins.
    Cumming AM; Jones GR; Wensley RT; Cundall RB
    Thromb Res; 1986 Jan; 41(1):43-56. PubMed ID: 3961726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of factor VIII:C activity on the activated partial thromboplastin time (aPTT) in the dog. Adaptation of the aPTT as a screening test for canine hemophilia A?].
    Mischke R
    Dtsch Tierarztl Wochenschr; 1993 Jun; 100(6):219-22. PubMed ID: 8339706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulation properties of fresh-frozin canine plasma during prolonged storage.
    Greene CE; Beck BB
    Am J Vet Res; 1980 Jan; 41(1):147-50. PubMed ID: 7362120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of aprotinin on the response of the activated partial thromboplastin time (APTT) to heparin.
    Francis JL; Howard C
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):35-40. PubMed ID: 7681330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical safety and cost of heparin titration using bedside activated clotting time.
    Thomason T; Riegel B; Jessen D; Smith SC; Gocka I; Rich M
    Am J Crit Care; 1993 Jan; 2(1):81-7. PubMed ID: 8353584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of the red blood cell mass of horses: toxic effect of heparin anticoagulant therapy.
    Duncan SG; Meyers KM; Reed SM
    Am J Vet Res; 1983 Dec; 44(12):2271-6. PubMed ID: 6660615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated coagulation and activated partial thromboplastin times in assessment and reversal of heparin-induced anticoagulation for cardiopulmonary bypass.
    Dauchot PJ; Berzina-Moettus L; Rabinovitch A; Ankeney JL
    Anesth Analg; 1983 Aug; 62(8):710-9. PubMed ID: 6869857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Problems by using whole blood in heparin measurements.
    Talstad I
    Thromb Haemost; 1982 Apr; 47(2):177-81. PubMed ID: 7101239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heparin and antiheparin in childhood. 3. Heparin level measurements and their importance in heparin monitoring].
    Domula M; Weissbach G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):146-61. PubMed ID: 6192049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin monitoring during coronary intervention: activated clotting time versus activated partial thromboplastin time.
    Nath FC; Muller DW; Rosenschein U; Ellis SG; Topol EJ
    Can J Cardiol; 1993 Nov; 9(9):797-801. PubMed ID: 8281479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum protein media are important factors in the manual hexadimethrine bromide (polybrene) test, experience in China.
    Liu F; Hu LH
    Transfus Clin Biol; 2005 Feb; 12(1):34-7. PubMed ID: 15814291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of haemolysis, lipaemia and bilirubinaemia on prothrombin time, activated partial thromboplastin time and thrombin time in plasma samples from healthy dogs.
    Moreno P; Ginel PJ
    Res Vet Sci; 1999 Dec; 67(3):273-6. PubMed ID: 10607508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Polybrene thrombin time--a simple new method for monitoring a fibrinolytic therapy].
    Lutze G; Schraermeyer T; Töpfer G; Urbahn H
    Z Med Lab Diagn; 1990; 31(3):169-75. PubMed ID: 2368472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial thromboplastin time in the presence of heparin: a rapid polybrene neutralization method.
    Israels ED
    Am J Clin Pathol; 1982 Mar; 77(3):321-4. PubMed ID: 6803572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma heparin: a simple, one-sample determination of both effect and concentration based on the activated partial thromboplastin time.
    Hoffman JJ; Meulendijk PN
    Clin Chim Acta; 1978 Aug; 87(3):417-24. PubMed ID: 679478
    [No Abstract]   [Full Text] [Related]  

  • 36. Extrinsic pathway inhibitor (EPI) and the post-heparin anticoagulant effect in tissue thromboplastin induced coagulation.
    Lindahl AK; Abildgaard U; Larsen ML; Aamodt LM; Nordfang O; Beck TC
    Thromb Res Suppl; 1991; 14():39-48. PubMed ID: 1658969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The impact of heparin bolus from dysfunctional lumen of dual lumen central venous catheter on activated partial thromboplastin time during hemodialysis: is additional heparinization necessary?].
    Sefer S; Kes P; Raić B; Heinrich B; Degoricija V; Szavits-Nossan J
    Acta Med Croatica; 2006 Jun; 60(3):281-5. PubMed ID: 16933844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of napsagatran (Ro 46-6240), a new synthetic thrombin inhibitor and of heparin in a canine model of coronary artery thrombosis: comparison with an ex vivo annular perfusion chamber model.
    Roux S; Tschopp T; Baumgartner HR
    J Pharmacol Exp Ther; 1996 Apr; 277(1):71-8. PubMed ID: 8613969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of plasma heparin by polybrene neutralization.
    Nash PV; Bjornsson TD
    Anal Biochem; 1984 May; 138(2):319-23. PubMed ID: 6742408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated partial thromboplastin time measurements in citrated canine plasma.
    Evans GO; Flynn RM
    J Comp Pathol; 1992 Jan; 106(1):79-82. PubMed ID: 1556259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.